NO802200L - Nye lipofile muramylpeptider og fremgangsmaate til deres fremstilling. - Google Patents

Nye lipofile muramylpeptider og fremgangsmaate til deres fremstilling.

Info

Publication number
NO802200L
NO802200L NO802200A NO802200A NO802200L NO 802200 L NO802200 L NO 802200L NO 802200 A NO802200 A NO 802200A NO 802200 A NO802200 A NO 802200A NO 802200 L NO802200 L NO 802200L
Authority
NO
Norway
Prior art keywords
lipofile
procedures
preparation
new
muramyl peptides
Prior art date
Application number
NO802200A
Other languages
English (en)
Other versions
NO157177B (no
NO157177C (no
Inventor
Lajos Tarcsay
Albert Hartmann
Gerhard Baschang
Jaroslav Stanek
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO802200L publication Critical patent/NO802200L/no
Publication of NO157177B publication Critical patent/NO157177B/no
Publication of NO157177C publication Critical patent/NO157177C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO802200A 1979-07-25 1980-07-22 Analogifremgangsmaate til fremstilling av farmakologisk virksomme muramylpeptider. NO157177C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH689379 1979-07-25
AU66581/81A AU6658181A (en) 1979-07-25 1981-01-23 Increasing antibiotic action of antibiotics

Publications (3)

Publication Number Publication Date
NO802200L true NO802200L (no) 1981-01-26
NO157177B NO157177B (no) 1987-10-26
NO157177C NO157177C (no) 1988-02-03

Family

ID=34862371

Family Applications (1)

Application Number Title Priority Date Filing Date
NO802200A NO157177C (no) 1979-07-25 1980-07-22 Analogifremgangsmaate til fremstilling av farmakologisk virksomme muramylpeptider.

Country Status (27)

Country Link
US (2) US4414204A (no)
EP (1) EP0025495B1 (no)
JP (1) JPS5649397A (no)
KR (1) KR840001617B1 (no)
AU (2) AU541147B2 (no)
CA (1) CA1183129A (no)
CS (1) CS276965B6 (no)
CY (1) CY1381A (no)
DD (1) DD153843A5 (no)
DE (1) DE3068304D1 (no)
DK (1) DK161025C (no)
ES (1) ES8105971A1 (no)
FI (1) FI75578C (no)
GR (1) GR69314B (no)
HK (1) HK85787A (no)
HU (1) HU188861B (no)
IE (1) IE50145B1 (no)
IL (1) IL60676A (no)
MX (1) MX9203368A (no)
MY (1) MY8700554A (no)
NO (1) NO157177C (no)
NZ (1) NZ194432A (no)
PL (2) PL127481B1 (no)
PT (1) PT71607A (no)
SG (1) SG38187G (no)
SU (2) SU1277905A3 (no)
ZA (1) ZA804487B (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
ZA804670B (en) * 1979-08-03 1981-07-29 Beecham Group Ltd Derivatives of clavulanic acid, a process for their preparation and their use
FI803077A (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
DE3169452D1 (en) * 1980-12-09 1985-04-25 Beecham Group Plc Derivatives of clavulanic acid, their preparation and their use
US4562182A (en) * 1980-12-23 1985-12-31 Beecham Group P.L.C. Compounds containing beta-lactams
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (no) * 1981-01-23 1984-09-26 Ciba Geigy Ag
US5189017A (en) * 1982-07-23 1993-02-23 Ciba-Geigy Corporation Use of sugar derivatives for the prophylaxis and treatment of virus infections
EP0102319B1 (de) * 1982-07-23 1987-08-19 Ciba-Geigy Ag Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen
US5334583A (en) * 1982-07-23 1994-08-02 Ciba-Geigy Corp. Use of sugar derivatives for the prophylaxis and treatment of virus infections
FI79330C (fi) * 1982-07-23 1989-12-11 Ciba Geigy Ag Foerfarande foer framstaellning av farmakologiskt verkande muramylpeptid-n-(2-fosfatidyloxietyl)-amider.
US4746651A (en) * 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
DE3572491D1 (en) * 1984-07-25 1989-09-28 Ciba Geigy Ag Phosphatidyl compounds, process for their preparation and their use
US4885285A (en) * 1984-09-13 1989-12-05 Ciba-Geigy Corporation Phosphorus compounds, processes for their manufacture, and their use
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US4873322A (en) * 1986-01-24 1989-10-10 Ciba-Geigy Corporation Saccharide derivatives and processes for their manufacture
US4916118A (en) * 1986-08-18 1990-04-10 Board Of Regents, The University Of Texas System Pharmaceutical administration systems containing chemotactic peptides
US5149529A (en) * 1988-04-08 1992-09-22 Board Of Trustees Of Leland Chiron Corporation Compositions and treatment for herpes simplex
US5416070A (en) * 1988-07-08 1995-05-16 Immunotherapeutics, Inc. Composition for macrophage activation
US4950645A (en) * 1988-07-08 1990-08-21 Immunotherapeutics, Inc. Composition for macrophage activation
US4994440A (en) * 1989-02-13 1991-02-19 Creaven Patrick J Method for the treatment of renal cell carcinoma
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
US6156319A (en) * 1994-07-25 2000-12-05 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex vaccine
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
AUPP059897A0 (en) * 1997-11-27 1998-01-08 Fujisawa Pharmaceutical Co., Ltd. New use of bicozamycin
US20040029842A1 (en) * 2001-12-18 2004-02-12 Gardner Wallace J. Triglyceride lowering, common cold and pneumonia prevention composition comprising tetracycline, and methods of treating or preventing diseases using same
WO2005013918A2 (en) 2003-02-28 2005-02-17 The Trustees Of The University Of Pennsylvania Compositions, methods and kits relating to poxvirus subunit vaccines
US20050079187A1 (en) * 2003-10-14 2005-04-14 Gardner Wallace J. Composition, kit and method for reducing plaque formation, tooth decay and incidence of caries
AU2005330703A1 (en) * 2004-07-19 2006-10-26 Baylor College Of Medicine Modulation of cytokine signaling regulators and applications for immunotherapy
US7868159B2 (en) * 2005-06-23 2011-01-11 Baylor College Of Medicine Modulation of negative immune regulators and applications for immunotherapy
US8367052B2 (en) 2007-03-26 2013-02-05 General Regeneratives Holdings Inc. Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies
JP2011505144A (ja) * 2007-11-30 2011-02-24 ベイラー カレッジ オブ メディシン 樹状細胞ワクチン組成物およびその使用
AU2010229835B2 (en) 2009-03-25 2015-01-15 The Board Of Regents Of The University Of Texas System Compositions for stimulation of mammalian innate immune resistance to pathogens
WO2011038002A1 (en) 2009-09-22 2011-03-31 Yale University Immunogenic epitopes as targets for universal cancer vaccines
CA2846486C (en) 2011-07-12 2019-08-20 Philadelphia Health & Education Corporation Novel clostridium difficile dna vaccine
RU2491922C1 (ru) * 2012-04-26 2013-09-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Способ повышения биоцидного и лечебного действия крема-суспензии с энрофлоксацином
RU2527330C2 (ru) * 2012-07-05 2014-08-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ повышения биоцидного и лечебного действия крема - суспензии с метронидазолом
WO2015116178A1 (en) 2014-01-31 2015-08-06 Thomas Jefferson University Fusion proteins for modulating regulatory and effector t cells
EP2951199A4 (en) 2013-01-31 2016-07-20 Univ Jefferson Fusion proteins for the modulation of regulatory and effector T cells
US10286065B2 (en) 2014-09-19 2019-05-14 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
US10576147B2 (en) 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
US20220089670A1 (en) 2018-12-28 2022-03-24 University Of Rochester Gene Therapy for BEST1 Dominant Mutations
AU2022239614A1 (en) 2021-03-19 2023-10-12 Icahn School Of Medicine At Mount Sinai Compounds for regulating trained immunity, and their methods of use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (no) * 1972-06-20 1973-12-27
US4001395A (en) * 1972-06-20 1977-01-04 Agence Nationale De Valorisation De La Recherche (Anvar) Hydrosoluble extracts of mycobacteria
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
CH613709A5 (en) 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
US4082735A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
US4082736A (en) * 1976-04-26 1978-04-04 Syntex (U.S.A.) Inc. Novel immunological adjuvant compounds and methods of preparation thereof
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
FR2368282A1 (fr) * 1976-10-22 1978-05-19 Anvar Adjuvant immunologique constitue par le p-amino-phenyl de n-acetyl-muramyl-l-alanyl-d-isoglutamine
US4268505A (en) * 1978-04-13 1981-05-19 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition comprising a nitrogen-containing polysaccharide and an antibiotic agent, and a method of treating an infectious disease therewith
FI803077A (fi) * 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider

Also Published As

Publication number Publication date
US4406890A (en) 1983-09-27
CS276965B6 (en) 1992-11-18
US4414204A (en) 1983-11-08
FI75578C (fi) 1988-07-11
IL60676A0 (en) 1980-09-16
DK161025B (da) 1991-05-21
FI75578B (fi) 1988-03-31
ZA804487B (en) 1981-07-29
SU1277905A3 (ru) 1986-12-15
NO157177B (no) 1987-10-26
EP0025495B1 (de) 1984-06-20
CS526280A3 (en) 1992-06-17
IE801533L (en) 1981-01-25
MX9203368A (es) 1992-09-01
HU188861B (en) 1986-05-28
FI802294A (fi) 1981-01-26
JPS5649397A (en) 1981-05-02
IE50145B1 (en) 1986-02-19
PL127481B1 (en) 1983-10-31
SU1277906A3 (ru) 1986-12-15
JPS6356239B2 (no) 1988-11-07
AU541147B2 (en) 1984-12-20
AU6658181A (en) 1982-11-04
NZ194432A (en) 1983-09-02
PT71607A (de) 1980-08-01
GR69314B (no) 1982-05-14
PL225870A1 (no) 1981-05-08
MY8700554A (en) 1987-12-31
NO157177C (no) 1988-02-03
CY1381A (en) 1987-12-18
CA1183129A (en) 1985-02-26
DD153843A5 (de) 1982-02-03
SG38187G (en) 1988-01-15
DK161025C (da) 1991-10-28
EP0025495A1 (de) 1981-03-25
KR830003511A (ko) 1983-06-21
PL131613B1 (en) 1984-12-31
DK319480A (da) 1981-01-26
IL60676A (en) 1984-10-31
DE3068304D1 (en) 1984-07-26
ES493633A0 (es) 1981-07-01
KR840001617B1 (ko) 1984-10-11
ES8105971A1 (es) 1981-07-01
AU6078880A (en) 1981-01-29
HK85787A (en) 1987-11-27

Similar Documents

Publication Publication Date Title
NO802200L (no) Nye lipofile muramylpeptider og fremgangsmaate til deres fremstilling.
NO802009L (no) Nye cyklopeptider og farmasoeytiske preparater herav, samt fremgangsmaate til deres fremstilling
DK495476A (da) Phenolethere og fremgangsmade til deres fremstilling
NO873640D0 (no) Nye cefemforbindelser og fremgangsmaate til deres fremstilling.
DK313276A (da) 2',4-dichlor-4'-benzoylureido-diphenylethere, fremgangsmade til deres fremstilling og deres anvendelse som insecticider
DK557876A (da) Polyhalogensteroider og fremgangsmade til deres fremstilling
DK457581A (da) 4,5-polymethylen-4-isothiazolin-3-oner fremgangsmaade til deres fremstilling og deres anvendelse
NO790626L (no) Nye antigenderivater og fremgangsmaate til deres fremstilling
DK488180A (da) Tetrazolyloxycarboxylsyreamider fremgangsmaade til deres fremstilling og deres anvendelse som herbicider
NO793192L (no) 4-fenyl-1,3-benzodiazepiner og fremgangsmaate til deres fremstilling.
NO893886D0 (no) Nye aminokinolinforbindelser og fremgangsmaate for deres fremstilling.
NO803451L (no) Nye 6alfa-fluor-9alfa-klor-prednisolon-17,21-diestere og fremgangsmaate ved fremstilling derav
NO790934L (no) 2,6-dialkoksybenzamider og fremgangsmaate til deres fremstilling
DK48482A (da) Azopigmentpraeparater,fremgangsmaade til deres fremstilling og deres anvendelse
DK319676A (da) 2',3,6'-trichlor-4-cyano-4'-benzoylureido-diphenylethere, fremgangsmade til deres fremstilling og deres anvendelse som insecticider
DK60982A (da) Oxalkylerede naphthol-novolaker,fremgangsmaade til deres fremstilling og deres anvendelse
NO802027L (no) Nye substituerte heterocykliske fenoksyaminer og fremgangsmaate til deres fremstilling
NO822796L (no) Aminoorganoaminosilaner, fremgangsmaate til deres fremstilling og deres anvendelse
DK407080A (da) Substituerede piperidiner og fremgangsmaade til fremstilling deraf
DK409277A (da) Pentapeptider og fremgangsmaade til deres fremstilling
NO156604C (no) Modifiserte krysotilasbest-fibre og fremgangsmaate til deres fremstilling.
NO784128L (no) Nye tetrapeptider og fremgangsmaate til deres fremstilling
NO156564C (no) Kompleks-salter og fremgangsmaate til fremstilling derav.
DK518578A (da) Nye phospholipidagtige forbindelser og fremgangsmaade til deres fremstilling
DK63080A (da) 25-hydroxy-24-oxochlostanderivater og fremgangsmaade til fremstilling deraf